N- (1-phenyl-2-arylethyl)-4,5-dihydro-3H-p yrrol-2-amine compounds as subtype selective modulators of alpha2B or alpha2B and alpha2C adrenoceptors

Details for Australian Patent Application No. 2009333620 (hide)

Owner Allergan, Inc.

Inventors Chow, Ken; Takeuchi, Janet A.; Li, Ling; Heidelbaugh, Todd M.; Nguyen, Phong X.; Corpuz, Evelyn G.; Fang, Wenkui K.; Sinha, Santosh C.; Garst, Michael E.

Agent Davies Collison Cave

Pub. Number AU-A-2009333620

PCT Pub. Number WO2010/077586

Priority 61/120,631 08.12.08 US

Filing date 7 December 2009

Wipo publication date 8 July 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 207/22 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4439 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/077586 Priority application(s): WO2010/077586

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009333625-Tissue repair assembly

2009333603-System and method for reconstruction of time-lapse data